Your browser doesn't support javascript.
loading
Disability accrual in primary and secondary progressive multiple sclerosis.
Harding-Forrester, Sam; Roos, Izanne; Nguyen, Ai-Lan; Malpas, Charles B; Diouf, Ibrahima; Moradi, Nahid; Sharmin, Sifat; Izquierdo, Guillermo; Eichau, Sara; Patti, Francesco; Horakova, Dana; Kubala Havrdova, Eva; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grand'Maison, Francois; Onofrj, Marco; Lugaresi, Alessandra; Grammond, Pierre; Ozakbas, Serkan; Amato, Maria Pia; Gerlach, Oliver; Sola, Patrizia; Ferraro, Diana; Buzzard, Katherine; Skibina, Olga; Lechner-Scott, Jeannette; Alroughani, Raed; Boz, Cavit; Van Pesch, Vincent; Cartechini, Elisabetta; Terzi, Murat; Maimone, Davide; Ramo-Tello, Cristina; Yamout, Bassem; Khoury, Samia Joseph; La Spitaleri, Daniele; Sa, Maria Jose; Blanco, Yolanda; Granella, Franco; Slee, Mark; Butler, Ernest; Sidhom, Youssef; Gouider, Riadh; Bergamaschi, Roberto; Karabudak, Rana; Ampapa, Radek; Sánchez-Menoyo, José Luis; Prevost, Julie; Castillo-Trivino, Tamara.
Afiliação
  • Harding-Forrester S; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Roos I; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Nguyen AL; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Malpas CB; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Diouf I; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Moradi N; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Sharmin S; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Izquierdo G; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Eichau S; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Patti F; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Horakova D; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Kubala Havrdova E; CORe, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Prat A; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Girard M; Multiple Sclerosis Unit, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
  • Duquette P; Multiple Sclerosis Unit, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain.
  • Grand'Maison F; Neuroscience, Department of Surgical and Medical Sciences and Advanced Technologies 'G.F. Ingrassia', University of Catania, Catania, Italy.
  • Onofrj M; Department of Neurology and Centre of Clinical Neuroscience, Charles University First Faculty of Medicine, Praha, Czech Republic.
  • Lugaresi A; Department of Neurology and Centre of Clinical Neuroscience, Charles University First Faculty of Medicine, Praha, Czech Republic.
  • Grammond P; Centre Hospitalier, Université de Montréal, Montreal, Québec, Canada.
  • Ozakbas S; Department of Neuroscience, Université de Montréal, Montreal, Québec, Canada.
  • Amato MP; Centre Hospitalier, Université de Montréal, Montreal, Québec, Canada.
  • Gerlach O; Faculté de Médecine, Université de Montréal, Montreal, Québec, Canada.
  • Sola P; Centre Hospitalier, Université de Montréal, Montreal, Québec, Canada.
  • Ferraro D; Faculté de Médecine, Université de Montréal, Montreal, Québec, Canada.
  • Buzzard K; Neuro Rive-Sud, Longueuil, Quebec, Canada.
  • Skibina O; Department of Neurosciences, Imaging and Clinical Sciences, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
  • Lechner-Scott J; UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Alroughani R; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Boz C; Centre intégré de santé et de services sociaux de Chaudière-Appalaches du Québec Centre de Recherche, Levis, Québec, Canada.
  • Van Pesch V; Department of Neurology, Dokuz Eylul University, Izmir, Turkey.
  • Cartechini E; Department of Neurological Siences, University of Florence, Florence, Italy.
  • Terzi M; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
  • Maimone D; Department of Neurology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
  • Ramo-Tello C; Neurology Unit, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy.
  • Yamout B; Department of Neuroscience, Azienda Ospedaliero-Universitaria di Modena, Modena, Emilia-Romagna, Italy.
  • Khoury SJ; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • La Spitaleri D; Department of Neurology, Box Hill Hospital, Box Hill, Victoria, Australia.
  • Sa MJ; Department of Neurology, Box Hill Hospital, Box Hill, Victoria, Australia.
  • Blanco Y; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Granella F; Department of Neurology, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Slee M; Department of Medicine, Al-Amiri Hospital, Kuwait City, Kuwait.
  • Butler E; Department of Neurology, Karadeniz Technical University, Trabzon, Turkey.
  • Sidhom Y; Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Gouider R; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
  • Bergamaschi R; Ondokuz Mayis Üniversitesi, Samsun, Turkey.
  • Karabudak R; UO Neurologia, Ospedale Garibaldi, Catania, Italy.
  • Ampapa R; Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
  • Sánchez-Menoyo JL; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
  • Prevost J; Department of Neurology, American University of Beirut, Beirut, Lebanon.
  • Castillo-Trivino T; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
J Neurol Neurosurg Psychiatry ; 94(9): 707-717, 2023 09.
Article em En | MEDLINE | ID: mdl-37068931
ABSTRACT

BACKGROUND:

Some studies comparing primary and secondary progressive multiple sclerosis (PPMS, SPMS) report similar ages at onset of the progressive phase and similar rates of subsequent disability accrual. Others report later onset and/or faster accrual in SPMS. Comparisons have been complicated by regional cohort effects, phenotypic differences in sex ratio and management and variable diagnostic criteria for SPMS.

METHODS:

We compared disability accrual in PPMS and operationally diagnosed SPMS in the international, clinic-based MSBase cohort. Inclusion required PPMS or SPMS with onset at age ≥18 years since 1995. We estimated Andersen-Gill hazard ratios for disability accrual on the Expanded Disability Status Scale (EDSS), adjusted for sex, age, baseline disability, EDSS score frequency and drug therapies, with centre and patient as random effects. We also estimated ages at onset of the progressive phase (Kaplan-Meier) and at EDSS milestones (Turnbull). Analyses were replicated with physician-diagnosed SPMS.

RESULTS:

Included patients comprised 1872 with PPMS (47% men; 50% with activity) and 2575 with SPMS (32% men; 40% with activity). Relative to PPMS, SPMS had older age at onset of the progressive phase (median 46.7 years (95% CI 46.2-47.3) vs 43.9 (43.3-44.4); p<0.001), greater baseline disability, slower disability accrual (HR 0.86 (0.78-0.94); p<0.001) and similar age at wheelchair dependence.

CONCLUSIONS:

We demonstrate later onset of the progressive phase and slower disability accrual in SPMS versus PPMS. This may balance greater baseline disability in SPMS, yielding convergent disability trajectories across phenotypes. The different rates of disability accrual should be considered before amalgamating PPMS and SPMS in clinical trials.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas com Deficiência / Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas com Deficiência / Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália